The key risks of holding QUBT are: (1) Financial risk: The company has a high cash burn rate of -$36.98M TTM and may need to dilute shareholders to fund operations, as seen in the increase in shares outstanding from 93.9M to 162.4M in a year. (2) Competitive risk: The quantum computing sector is highly competitive, with well-funded players like Quantinuum potentially dominating the market. (3) Macro risk: With a beta of 3.79, the stock is highly sensitive to market swings, and a downturn in speculative tech stocks could cause significant losses. (4) Company-specific risk: The company's technology may not achieve commercial viability, and revenue growth has been inconsistent. The most severe risk is a cash crunch leading to bankruptcy or a massive dilution, which could result in a loss of up to -74% from the high, as seen in the max drawdown.

The 12-month forecast for QUBT is highly uncertain. In a bull case (25% probability), the stock could reach $18.33 to $30.00, driven by major contract wins and sector momentum. In a base case (45% probability), the stock could trade between $9.23 and $12.00, as the company makes modest progress but remains unprofitable. In a bear case (30% probability), the stock could fall to $6.18 or lower, if the company faces cash flow issues or the sector corrects. The most likely scenario is the base case, which assumes that QUBT continues to develop its technology but does not achieve explosive growth in the near term. Investors should be prepared for significant volatility and the possibility of substantial losses.

QUBT is significantly overvalued based on its current financials. The trailing PS ratio of 2,474.6x is astronomical, and the forward PS of 1.14x assumes revenue of $1.48 billion, which is highly speculative given the current annual revenue of under $1 million. The company has negative net income and a negative gross margin, indicating that it loses money on every sale. Compared to its own history, the stock is trading near the lower end of its 52-week range, but that does not make it cheap. The market is pricing in a massive revenue inflection that may never materialize, making the stock overvalued relative to its fundamentals. Investors should be cautious about paying such a high multiple for a company with minimal revenue and no clear path to profitability.

QUBT is not a good buy for most investors due to its extreme valuation and high risk. The stock trades at a trailing PS ratio of 2,474.6x, and the company has negative earnings and cash flow. While the average analyst target of $18.33 implies a 98.6% upside, the wide range of targets (from $10 to $30) and the lack of a consensus recommendation indicate high uncertainty. The biggest downside risk is a continued decline to the 52-week low of $6.18, a -33% loss. However, for investors with a very high risk tolerance and a long-term view, QUBT could be a speculative buy if they believe in the quantum computing revolution and the company's unique technology. It is only suitable for a small portion of a portfolio that can withstand significant volatility.

QUBT is more suitable for long-term investment, but only for investors with a very high risk tolerance. The company is in the early stages of commercialization, and it may take years to achieve meaningful revenue and profitability. The stock's high beta of 3.79 and poor short-term performance make it unsuitable for short-term trading, as it is prone to sharp swings. The company does not pay a dividend, and earnings visibility is low, making it a speculative long-term bet on the quantum computing industry. A suggested minimum holding period would be 5 years or more, to allow the technology to mature and the company to potentially reach a scale where it can generate sustainable revenue. However, even long-term investors should be prepared for the possibility of a total loss, given the high risks involved.